• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板 PD-L1 通过维持 AKT 信号通路的激活来抑制储存诱导的细胞凋亡。

Platelet PD-L1 inhibits storage-induced apoptosis by sustaining activation of the AKT signalling pathway.

机构信息

Department of Transfusion Medicine, Huashan Hospital, Fudan University, Shanghai, China; Department of Transfusion Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Transfusion Medicine, Huashan Hospital, Fudan University, Shanghai, China.

出版信息

Thromb Res. 2024 Aug;240:109056. doi: 10.1016/j.thromres.2024.109056. Epub 2024 May 31.

DOI:10.1016/j.thromres.2024.109056
PMID:38878739
Abstract

Platelet apoptosis is irreversible under current storage conditions in blood banks. Studies have shown that programmed cell death ligand 1 (PD-L1) in tumour cells is required for neoplastic progression, tumour recurrence and metastasis by regulating apoptosis. However, whether PD-L1 is involved in storage-induced apoptosis in platelets remains poorly understood. In this study, we explored whether PD-L1 on platelets participated in the regulation of storage-induced apoptosis under blood bank conditions, as well as the underlying mechanism. Several apoptotic events in platelets from humans and PD-L1-knockout mice during storage under blood bank conditions were measured. The mechanism by which storage-induced apoptosis was regulated by platelet-intrinsic PD-L1 signalling was further investigated. Our results showed that PD-L1 in platelets progressively decreased. There was a strong negative correlation between platelet PD-L1 expression and the phosphatidylserine (PS) externalization rate and cleaved caspase-3 level and a positive correlation with anti-apoptosis protein Bcl-xl. Ex vivo, PD-L1-/- platelets stored at 22 °C showed rapid apoptosis via an intrinsic mitochondria-dependent pathway over time. Likewise, inhibiting PD-L1 signalling with BMS-1166 accelerated apoptosis by intrinsic mitochondria-dependent pathway. Coimmunoprecipitation analysis revealed that PD-L1 could bind AKT in platelets, and the binding capacity of both showed a progressive decrease with time. Finally, the decrease in PD-L1 expression levels during storage could be attributed to a complex process of progressive secretion. Therefore, platelet PD-L1 inhibits storage-induced apoptosis by sustaining activation of the AKT signalling pathway, which is expected to become a target for alleviating platelet storage lesions (PSLs) under current blood bank conditions.

摘要

在当前血库的储存条件下,血小板凋亡是不可逆的。研究表明,肿瘤细胞中的程序性细胞死亡配体 1(PD-L1)通过调节细胞凋亡,对于肿瘤的进展、复发和转移是必需的。然而,PD-L1 是否参与血小板的储存诱导凋亡仍知之甚少。在本研究中,我们探讨了 PD-L1 是否参与了血库条件下储存诱导的血小板凋亡的调节,以及潜在的机制。测量了人类和 PD-L1 敲除小鼠血小板在血库条件下储存过程中的几种凋亡事件。进一步研究了血小板内在 PD-L1 信号调节储存诱导凋亡的机制。我们的结果表明,血小板中的 PD-L1 逐渐减少。血小板 PD-L1 表达与磷脂酰丝氨酸(PS)外翻率和裂解的 caspase-3 水平呈强烈负相关,与抗凋亡蛋白 Bcl-xl 呈正相关。在体,PD-L1-/-血小板在 22°C 储存时,通过内在的线粒体依赖性途径,随着时间的推移迅速发生凋亡。同样,用 BMS-1166 抑制 PD-L1 信号也会通过内在的线粒体依赖性途径加速凋亡。共免疫沉淀分析表明,PD-L1 可以与血小板中的 AKT 结合,两者的结合能力随时间呈逐渐下降趋势。最后,储存过程中 PD-L1 表达水平的降低可归因于一个渐进的分泌复杂过程。因此,血小板 PD-L1 通过维持 AKT 信号通路的激活来抑制储存诱导的凋亡,这有望成为缓解当前血库条件下血小板储存损伤(PSLs)的靶点。

相似文献

1
Platelet PD-L1 inhibits storage-induced apoptosis by sustaining activation of the AKT signalling pathway.血小板 PD-L1 通过维持 AKT 信号通路的激活来抑制储存诱导的细胞凋亡。
Thromb Res. 2024 Aug;240:109056. doi: 10.1016/j.thromres.2024.109056. Epub 2024 May 31.
2
Intrinsic apoptosis circumvents the functional decline of circulating platelets but does not cause the storage lesion.内在凋亡可避免循环血小板的功能下降,但不会导致贮存损伤。
Blood. 2018 Jul 12;132(2):197-209. doi: 10.1182/blood-2017-11-816355. Epub 2018 May 21.
3
PD-1/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway.PD-1/PD-L1 阻断通过 PI3K/Akt/mTOR 信号通路挽救胃肠道间质瘤中耗竭的 CD8+ T 细胞。
Cell Prolif. 2019 May;52(3):e12571. doi: 10.1111/cpr.12571. Epub 2019 Feb 3.
4
PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway.PD-L1 通过激活 PI3K-AKT 信号通路调节急性髓系白血病细胞的增殖和凋亡。
Sci Rep. 2022 Jul 6;12(1):11444. doi: 10.1038/s41598-022-15020-0.
5
Akt pathway activation reduces platelet apoptosis and contributes to the increase of platelet counts in solid tumor patients.Akt 通路激活可减少血小板凋亡,并有助于增加实体瘤患者的血小板计数。
Platelets. 2022 Oct 3;33(7):1009-1017. doi: 10.1080/09537104.2022.2026908. Epub 2022 Jan 24.
6
Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signaling.巨噬细胞移动抑制因子通过 CXCR7 依赖性 Akt 信号限制血小板的激活诱导凋亡。
Circ Res. 2014 Nov 7;115(11):939-49. doi: 10.1161/CIRCRESAHA.115.305171. Epub 2014 Sep 29.
7
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer.转移性乳腺癌患者循环肿瘤细胞和血小板上的 PD-L1 表达。
PLoS One. 2021 Nov 15;16(11):e0260124. doi: 10.1371/journal.pone.0260124. eCollection 2021.
8
Immune-independent acquired resistance to PD-L1 antibody initiated by PD-L1 upregulation via PI3K/AKT signaling can be reversed by anlotinib.通过 PI3K/AKT 信号通路上调 PD-L1 引发的 PD-L1 抗体免疫无关获得性耐药可被安罗替尼逆转。
Cancer Med. 2023 Jul;12(14):15337-15349. doi: 10.1002/cam4.6195. Epub 2023 Jun 23.
9
Novel roles of c-Met in the survival of renal cancer cells through the regulation of HO-1 and PD-L1 expression.c-Met 通过调节 HO-1 和 PD-L1 的表达在肾癌细胞存活中的新作用。
J Biol Chem. 2015 Mar 27;290(13):8110-20. doi: 10.1074/jbc.M114.612689. Epub 2015 Feb 2.
10
PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation.程序性死亡受体配体1(PD-L1)通过维持磷脂酰肌醇-3-激酶(PI3K)/蛋白激酶B(AKT)信号通路的激活来促进乳腺癌干细胞中八聚体结合转录因子4(OCT4)和同源盒蛋白NANOG(Nanog)的表达。
Int J Cancer. 2017 Oct 1;141(7):1402-1412. doi: 10.1002/ijc.30834. Epub 2017 Jun 30.

引用本文的文献

1
Programmed Death-1 Ligand 1 Domain Organization, Signaling Motifs, and Interactors in Cancer Immunotherapy.癌症免疫治疗中的程序性死亡-1配体1结构域组织、信号基序及相互作用分子
Cancers (Basel). 2025 May 12;17(10):1635. doi: 10.3390/cancers17101635.